Policy Notices

• Notice to Extend PA-18-794
  (NOT-HS-22-016)
  Agency for Healthcare Research and Quality
  

• Notice to Extend PA-18-795
  (NOT-HS-22-017)
  Agency for Healthcare Research and Quality
  

General Notices

• Notice of Preapplication Webinar for RFA-CA-22-016, Pediatric Immunotherapy Network (PIN) (U01 Clinical Trial Optional)
  (NOT-CA-22-089)
  National Cancer Institute
  

• Notice of Correction to Eligibility for RFA-HD-23-002 NICHD Neonatal Research Network (NRN): Clinical Centers (UG1 Clinical Trial Optional)
  (NOT-HD-22-024)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  

• Solicitation of Nominations for the 2022 National Human Genome Research Institutes Outstanding Award for Enhancing Diversity, Equity, Inclusion, and Accessibility in the Genomics Workforce
  (NOT-HG-22-014)
  National Human Genome Research Institute
  

• Notice of Change to RFA-OD-22-003, "Center for Coordination of Analysis, Science, Enhancement, and Logistics (CASEL) in Tobacco Regulatory Science (U54 Clinical Trial Not Allowed)"
  (NOT-OD-22-155)
  Office of Disease Prevention
  

• Notice of Pre-Application Webinar: Harnessing Data Science for Health Discovery and Innovation in Africa: Research Education Program (UE5 Clinical Trial Not Allowed) & Partnership for Innovation Research Projects (U01 Clinical Trial Not Allowed)
  (NOT-RM-22-015)
  Office of Strategic Coordination (Common Fund)
  

• Request for Information: Inviting comments and suggestions from stakeholders on Pediatric Medical Devices Public-Private Partnership
  (NOT-EB-22-008)
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  

• Request for Information (RFI): NINDS/NICHD Workshop on Cerebral Palsy Research
  (NOT-NS-22-105)
  National Institute of Neurological Disorders and Stroke
  

Notice of Changes to Funding Opportunities

• Notice of Change in Funding Opportunity RFA-RM-22-015, IND-enabling Studies of Somatic Genome Editing Therapeutic Leads (U19, Clinical Trial Not allowed)
  (NOT-RM-22-014)
  Office of Strategic Coordination (Common Fund)
  

Notices of Special Interest

• Notice of Special Interest (NOSI): Innovative Technologies to Improve Assessments, Interventions, and Outcomes for Individuals with Intellectual and Developmental Disabilities (R43/R44)
  (NOT-HD-22-009)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  

• Notice of Special Interest (NOSI): Availability of Administrative Supplements for the INCLUDE (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) Project
  (NOT-OD-22-137)
  Office of the Director, NIH
  John E. Fogarty International Center
  National Center for Advancing Translational Sciences
  National Cancer Institute
  National Eye Institute
  National Heart, Lung, and Blood Institute
  National Institute on Aging
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of General Medical Sciences
  National Institute on Minority Health and Health Disparities
  National Institute of Neurological Disorders and Stroke
  

• Notice of Special Interest: Administrative Supplements to NIH-funded T32 and TL1 Training Grants to Better Integrate Behavioral and Social Sciences (BSS) with other Health-Related Sciences
  (NOT-OD-22-141)
  Office of Behavioral and Social Sciences Research
  National Center for Advancing Translational Sciences
  National Center for Complementary and Integrative Health
  National Cancer Institute
  National Human Genome Research Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Environmental Health Sciences
  National Institute of Nursing Research
  

Funding Opportunities

• Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional)
  (PAR-22-181)
  National Institute of Neurological Disorders and Stroke
  National Eye Institute
  National Institute on Drug Abuse
  National Institute of Mental Health
  Application Receipt Date(s): June 06, 2025
  
  

• Measures and Methods for Research on Family Caregivers for People Living with Alzheimers Disease and Related Dementias (AD/ADRD) (R01 Clinical Trial Not Allowed)
  (RFA-AG-23-022)
  National Institute on Aging
  Application Receipt Date(s): October 20, 2022
  
  

• Measures and Methods for Research on Family Caregivers for People Living with Alzheimers Disease and Related Dementias (AD/ADRD) (R21 Clinical Trial Not Allowed)
  (RFA-AG-23-023)
  National Institute on Aging
  Application Receipt Date(s): October 20, 2022
  
  

• Novel Drug (DDT) and Medical Device Development Tools (MDDT) to Help Expedite Creation and Regulatory Approvals of New Therapies for Substance Use Disorders (SUD) (R41/R42 Clinical Trial Optional)
  (RFA-DA-23-019)
  National Institute on Drug Abuse
  Application Receipt Date(s): November 14, 2022
  
  

• Novel Drug (DDT) and Medical Device Development Tools (MDDT) to Help Expedite Creation and Regulatory Approvals of New Therapies for Substance Use Disorders (SUD) (R43/R44 Clinical Trial Optional)
  (RFA-DA-23-020)
  National Institute on Drug Abuse
  Application Receipt Date(s): November 14, 2022
  
  

• Stakeholder Engagement Innovation Center for Advancing Health Equity in Type 2 Diabetes Research (U2C - Clinical Trial Not Allowed)
  (RFA-DK-22-001)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): October 26, 2022
  
  

• Multidisciplinary K12 Urologic Research (KURe) Career Development Program (K12 Clinical Trial Optional)
  (RFA-DK-22-006)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): October 27, 2022
  
  

• Limited Competition for the Continuation of HiLo: Pragmatic Trial of Higher versus Lower Serum Phosphate Targets in Patients Undergoing Hemodialysis Clinical Centers (UH3- Clinical Trial Required)
  (RFA-DK-22-501)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): October 19, 2022
  
  

• Limited Competition for the Continuation of the NIDDK Diabetic Foot Consortium - Clinical Research Units (U01 Clinical Trial Optional)
  (RFA-DK-22-509)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): August 17, 2022
  
  

• Research Coordinating Center to Support Climate Change and Health Community of Practice (U24 Clinical Trial Not Allowed)
  (RFA-ES-22-003)
  National Institute of Environmental Health Sciences
  John E. Fogarty International Center
  National Cancer Institute
  National Heart, Lung, and Blood Institute
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Mental Health
  National Institute on Minority Health and Health Disparities
  National Institute of Nursing Research
  Application Receipt Date(s): August 25, 2022
  
  

• Data Management Coordinating Center for Diagnostic Centers of Excellence (U2C Clinical Trial Not Allowed)
  (RFA-NS-22-051)
  National Institute of Neurological Disorders and Stroke
  National Eye Institute
  National Human Genome Research Institute
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  Application Receipt Date(s): August 10, 2022